resiquimod has been researched along with ent-crizotinib in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (ent-crizotinib) | Trials (ent-crizotinib) | Recent Studies (post-2010) (ent-crizotinib) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 11 | 0 | 11 |
| Protein | Taxonomy | resiquimod (IC50) | ent-crizotinib (IC50) |
|---|---|---|---|
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 0.5289 | |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | 0.68 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alwan, H; Bista, M; Breed, J; Davies, NL; Eckersley, K; Fillery, S; Foote, KM; Goodwin, L; Jones, DR; Käck, H; Kettle, JG; Lau, A; Nissink, JW; Read, J; Scott, JS; Taylor, B; Walker, G; Wissler, L; Wylot, M | 1 |
1 other study(ies) available for resiquimod and ent-crizotinib
| Article | Year |
|---|---|
Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; DNA Repair Enzymes; Drug Discovery; Humans; Models, Molecular; Phosphoric Monoester Hydrolases; Rats; RNA, Small Interfering; Structure-Activity Relationship | 2016 |